Groundbreaking studies indicate Semaglutide and Tirzepatide may reduce alcohol consumption in individuals with obesity Post author: Post published:December 1, 2023 Post category:uncategorized The impact of semaglutide and tirzepatide and glucagon-like peptide-1 receptor agonist medications on alcohol consumption. You Might Also Like Can odors help fight infection? Nematode research suggests so August 12, 2024 Partnership with Microsaic Systems for Optimer-enabled water monitoring June 14, 2024 Can cutting back on extra virgin olive oil make your heart healthier? July 25, 2024